INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 139 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,180,000 | +2.3% | 434,548 | -5.5% | 0.00% | 0.0% |
| Q3 2017 | $4,085,000 | -43.4% | 460,056 | -19.4% | 0.00% | -33.3% |
| Q2 2017 | $7,217,000 | +20.6% | 570,469 | +0.2% | 0.00% | 0.0% |
| Q1 2017 | $5,986,000 | +13.6% | 569,512 | -0.6% | 0.00% | 0.0% |
| Q4 2016 | $5,269,000 | -22.7% | 572,664 | -0.9% | 0.00% | -25.0% |
| Q3 2016 | $6,814,000 | -9.5% | 577,955 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $7,528,000 | -19.2% | 581,756 | -0.1% | 0.00% | -33.3% |
| Q1 2016 | $9,314,000 | -44.2% | 582,472 | -0.1% | 0.01% | -40.0% |
| Q4 2015 | $16,697,000 | -19.9% | 583,172 | -20.4% | 0.01% | -28.6% |
| Q3 2015 | $20,842,000 | -11.3% | 732,349 | +11.9% | 0.01% | 0.0% |
| Q2 2015 | $23,501,000 | +23.7% | 654,280 | +100.2% | 0.01% | +16.7% |
| Q1 2015 | $18,993,000 | +53.2% | 326,738 | +11.1% | 0.01% | +50.0% |
| Q4 2014 | $12,397,000 | +15.1% | 294,038 | +5.9% | 0.01% | 0.0% |
| Q3 2014 | $10,769,000 | +23.2% | 277,700 | -0.8% | 0.01% | +33.3% |
| Q2 2014 | $8,741,000 | +3.4% | 279,885 | +37.1% | 0.01% | 0.0% |
| Q1 2014 | $8,456,000 | +190.3% | 204,098 | +171.2% | 0.01% | +200.0% |
| Q4 2013 | $2,913,000 | – | 75,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |